Keros Therapeutics

KROS

10.0701.47% ( -0.150 )

Closed: Jul 31, 16:00:01 (EDT)

Q1 FY2026 Earnings

Financial report interval: 2025.12.31 - 2026.03.31

Preview: Keros Therapeutics(KROS) predict that the Revenue is 367 K (-99.83%), Miss estimate;the EBIT is -25.88 M (-117%), Beat estimate;the EPS is -1.21 (-133.4%), Miss estimate.

Actual

YoY

Estimate

YoY

Vs estimate

YoY

RevenueMiss expectations

0.00B99.83%

0.00B99.20%

-0.00B0.63%

EBITExceed expectations

-0.03B117.02%

-0.03B121.98%

+0.01B4.96%

EPSMiss expectations

-1.21133.43%

-1.0229128.26%

-0.18715.17%

Revenue

ActualEstimateUnit: USD

EBIT

ActualEstimateUnit: USD

Net income

ActualEstimateUnit: USD

EPS

ActualEstimateUnit: USD